Hologen is raising 150 million dollars in Series A funding to scale its Large Medicine Models for cl...

Hologen is raising 150 million dollars in Series A funding to scale its Large Medicine Models for clinical trial optimization. Co-founded by Eric Schmidt, the startup recently secured a 200 million dollar deal to de-risk Parkinson's gene therapy trials. By modeling biological variation from millions of patient records, Hologen aims to cut trial recruitment needs by 50 percent. This shift could systematically solve high Phase III failure rates and lower drug development costs globally. 🧬🚀💊

#AI #Biotech #ClinicalTrials #VentureCapital #HealthTech